We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NPCE icon
3426
Neuropace
NPCE
$513M
$32K ﹤0.01%
+1,343
New +$31.2K
NRC icon
3427
NRC Health Common Stock
NRC
$473M
$32K ﹤0.01%
694
-642
-48% -$30.5K
ORIC icon
3428
Oric Pharmaceuticals
ORIC
$1.42B
$32K ﹤0.01%
1,863
+311
+20% +$6.82K
TBI
3429
Trueblue
TBI
$310M
$32K ﹤0.01%
1,142
-13,825
-92% -$368K
TCMD icon
3430
Tactile Systems Technology
TCMD
$545M
$32K ﹤0.01%
618
-333
-35% -$18K
TISI icon
3431
Team
TISI
$104M
$32K ﹤0.01%
486
+124
+34% +$11.3K
NESR
3432
National Energy Services Reunited Corp
NESR
$3.63B
$32K ﹤0.01%
2,223
-459
-17% -$6.17K
GMDA
3433
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$32K ﹤0.01%
4,953
+1,937
+64% +$13.4K
DSKE
3434
DELISTED
Daseke, Inc. Common Stock
DSKE
$32K ﹤0.01%
4,849
+1,024
+27% +$7.43K
CEQP
3435
DELISTED
Crestwood Equity Partners LP
CEQP
$32K ﹤0.01%
1,071
-2,376
-69% -$70.7K
HCCI
3436
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$32K ﹤0.01%
1,072
+65
+6% +$1.93K
PRVB
3437
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$32K ﹤0.01%
3,835
-12,928
-77% -$104K
MBII
3438
DELISTED
Marrone Bio Innovations, Inc.
MBII
$32K ﹤0.01%
19,516
+4,904
+34% +$8.2K
BOWX
3439
DELISTED
BowX Acquisition Corp. Class A Common Stock
BOWX
$32K ﹤0.01%
2,825
-10,001
-78% -$121K
WPG
3440
DELISTED
Washington Prime Group Inc.
WPG
$32K ﹤0.01%
14,946
+14,643
+4,833% +$38.4K
ACTG icon
3441
Acacia Research
ACTG
$451M
$31K ﹤0.01%
4,566
+2,441
+115% +$14.5K
APLT
3442
DELISTED
Applied Therapeutics
APLT
$31K ﹤0.01%
1,457
-302
-17% -$5.72K
APRE icon
3443
Aprea Therapeutics
APRE
$8.17M
$31K ﹤0.01%
324
-179
-36% -$16.5K
ARES icon
3444
Ares Management
ARES
$32.3B
$31K ﹤0.01%
490
+136
+38% +$7.6K
BAK icon
3445
Braskem
BAK
$881M
$31K ﹤0.01%
+1,287
New +$25.7K
CRBP icon
3446
Corbus Pharmaceuticals
CRBP
$184M
$31K ﹤0.01%
566
-1,770
-76% -$98.2K
DHX icon
3447
DHI Group
DHX
$166M
$31K ﹤0.01%
8,895
+2,803
+46% +$8.88K
FMNB icon
3448
Farmers National Banc Corp
FMNB
$952M
$31K ﹤0.01%
1,987
-42
-2% -$705
HOFT icon
3449
Hooker Furnishings Corp
HOFT
$163M
$31K ﹤0.01%
894
-67
-7% -$2.5K
ITOS
3450
DELISTED
iTeos Therapeutics
ITOS
$31K ﹤0.01%
1,224
+21
+2% +$500
136 137
138
139 140

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.